RxDoctor Payments Data

Laura Korman, MD

Gynecology · Portland, ORNPI 1922034115

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 106 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 23.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $542 and has fallen 73.1% since, to $146 in 2025.

$2,485in general payments, 2019–2025

Across 106 payments — averaging $23.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$575
  • Merck$265
  • Therapeuticsmd, Inc.$176
  • Gen-probe Sales & Service, Inc.$143
  • Novo Nordisk$139
  • Myriad Women's Health, Inc.$126
  • plus $1K from 24 others

What the payments were for

  • Food & beverage$2,485100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,485 in reported general payments places this provider in the 75th percentile of 34 gynecology providers in Oregon.

See all gynecology providers in Oregon

Medicare billing

Part B allowed, 2024
$9,204
Medicare patients
36
Services billed
89

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FemringEstradiol Acetate12$9,578
Estradiol59$4,542
Estradiol (Twice Weekly)Estradiol27$3,081
Estradiol (Once Weekly)Estradiol18$2,570
DottiEstradiol11$2,044
ProgesteroneProgesterone, Micronized37$1,739
ValacyclovirValacyclovir Hcl11$399

Paid to pharmacies, not to this prescriber.

Other gynecology in Portland

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →